No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Bausch Health Companies Inc. is a global healthcare enterprise dedicated to the creation, production, and sale of a diverse array of pharmaceutical, medical device, and over-the-counter items. Its primary therapeutic focus areas include eye health, digestive system issues, and dermatological conditions. The company's operations are strategically organized into five key divisions: Bausch + Lomb, which specializes in vision care, surgical solutions, and ophthalmic pharmaceuticals; Salix, concentrating on gastroenterology products within the United States; International Rx, offering a broad portfolio encompassing Solta products, branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across numerous international markets in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East; Ortho Dermatologics, providing dermatological products in the U.S. and Solta medical aesthetic devices globally; and Diversified Products, covering pharmaceutical products in neurology and other therapeutic classes, alongside generic and dentistry items in the United States. Previously known as Valeant Pharmaceuticals International, Inc., the company adopted its current name in July 2018 and maintains its headquarters in Laval, Canada.

• China Resources Jiangzhong Pharmaceutical Co.,Ltd
• Dermapharm Holding SE
• Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
• Shandong Buchang Pharmaceuticals Co., Ltd.
• Curaleaf Holdings, Inc.
• Shanghai Haoyuan Chemexpress Co., Ltd.
• Neuland Laboratories Limited
• Fujian Cosunter Pharmaceutical Co., Ltd.